Improvement in clinical trial disclosures and analysts' forecast accuracy : evidence from the pharmaceutical industry
Year of publication: |
October 2017
|
---|---|
Authors: | Hao, Maggie ; Forgione, Dana A. ; Guo, Liang ; Zhang, Hongxian |
Published in: |
Review of quantitative finance and accounting. - New York, NY : Springer, ISSN 0924-865X, ZDB-ID 1087855-5. - Vol. 49.2017, 3, p. 785-810
|
Subject: | Non-financial disclosure | Analyst forecast accuracy | Clinical trial disclosures | Pharmaceutical companies | Pharmaindustrie | Pharmaceutical industry | Finanzanalyse | Financial analysis | Unternehmenspublizität | Corporate disclosure | Prognoseverfahren | Forecasting model | Prognose | Forecast | Arzneimittel | Pharmaceuticals | Auskunftspflicht | Disclosure regulation |
-
The effects of CSR report mandatory policy on analyst forecasts : evidence from Taiwan
Tseng, Tzu-Yun, (2022)
-
How does investor relations disclosure affect analysts' forecasts?
Chang, Millicent, (2014)
-
Benefits of management disclosure precision on analysts' forecasts
Chi, Yu-ho, (2014)
- More ...
-
Hao, Maggie, (2016)
-
Uncertainty and liquidity in corporate bond market
Guo, Liang, (2017)
-
Corruption, governance, and public pension funds
Zhang, Hongxian, (2018)
- More ...